Abstract:OBJECTIVE: In some women, hot flashes and other symptoms attributed to menopause persist for many years after the cessation of menses. The frequency and severity of such symptoms and response to hormone therapy in older women have not been well documented.METHODS: We used data from the Heart and Estrogen/Progestin Replacement Study, a blinded, clinical trial among 2763 women with documented coronary disease and a uterus who were randomized to receive either conjugated estrogens 0.625 mg plus medroxyprogesterone acetate 2.5 mg in one tablet or placebo. Participants were queried at baseline and annually regarding menopausal symptoms. Breast symptoms were self-reported, and uterine bleeding was recorded on a daily diary.RESULTS: Symptoms associated with menopause were relatively common among Heart and Estrogen/Progestin Replacement Study participants, whose average age was 67 years and who averaged 18 years since menopause. At baseline, 16% of women reported frequent hot flashes, 26% vaginal dryness, 10% genital irritation, 55% trouble sleeping, and 53% early awakening. Women assigned to hormone therapy reported less frequent hot flashes, vaginal dryness, and trouble sleeping compared with women assigned to Placebo, but more frequent vaginal discharge, genital irritation, uterine bleeding, and breast symptoms. The reporting of breast symptoms among women in the hormone group decreased from 40% at 1 year to 13% by the 4th year. Uterine bleeding was reported by 31% and spotting by an additional 33% of women in the hormone group during the lst year of treatment; by the 4th year, these proportions had fallen to 11% and 20%, respectively.CONCLUSION: Symptoms typically attributed to menopause are common in elderly women. Postmenopausal hormone therapy reduces hot flashes, trouble sleeping, and vaginal dryness, but at standard doses in elderly women is associated with vaginal discharge, genital irritation, uterine bleeding, and breast symptoms. (C) 2002 by The American College of Obstetricians and Gynecologists.

The boundary correlation function of fixed-to-free boundary-condition-changing operators in a square-lattice Ising model

Congenital coronary anomalies are not uncommon and consideration should be given to screening first degree relatives.

Potential Mechanisms of Age Acceleration Caused by Estrogen Deprivation: Do Endocrine Therapies Carry the Same Risks?

Sava: Committed to Organizational Learning

Alpha-2 adrenergic receptor localization in the rat heart and kidney using autoradiography and tritiated rauwolscine.

Estrogen therapy for geriatric osteoporosis: just one ball in a complex juggling act

From Menopause to Neurodegeneration—Molecular Basis and Potential Therapy

Hormone Replacement Therapy and Alzheimer's Disease: Current State of Knowledge and Implications for Clinical Use

Influence of the Onset of Menopause on the Risk of Developing Alzheimer's Disease

Estrogens as neuroprotectants: Estrogenic actions in the context of cognitive aging and brain injury

The peri-menopause in a woman’s life: a systemic inflammatory phase that enables later neurodegenerative disease

Intramolecular pi-pi stacking in diaquabis(2-hydroxybenzoato-kappaO)bis(1,10-phenanthroline-kappa2N,N')strontium(II).

U S WEST Implements a Cogent Analytical Model for Optimal Vehicle Replacement

Estrogen and cardiovascular disease

[Quaking mice: study of sleep and of epileptic seizures].

Menopausal Symptoms in Older Women and the Effects of Treatment with Hormone Therapy

Hormones, herbal preparations and nutriceuticals for a better life after the menopause: part I

Esophageal reflux: massive hiatus hernia on hepatobiliary study.

From cardiovascular protection to cardiovascular risk: the metamorphosis of menopausal hormone therapy

Transitions in metabolic and immune systems from pre-menopause to post-menopause: implications for age-associated neurodegenerative diseases

Cardiovascular Changes in Menopause